Investment
Features
FeesSafety
Academy
More
Pluang+

Kronox Holdings offers strong investment potential with rising TiO₂ demand and improved cash flow.

Market News
23 Sep 2026
Seeking Alpha
View Source
Bullish
Kronox Holdings offers strong investment potential with rising TiO₂ demand and improved cash flow.

Kronox Holdings is positioned as a promising investment due to growing demand for chloride-based titanium dioxide (TiO₂). The company improved its financial health by reducing inventories by 27% year-over-year, which generated $120 million in cash inflows and doubled its operating cash flow to $2 million. Trading at a sales multiple of 0.5, Kronox is undervalued compared to its sector peers, suggesting a potential 100% upside for investors. This makes Kronox an attractive option for those seeking exposure to the commodity chemicals market with better margin structures.

Kronos Worldwide and its market context are shown here with Pluang's Basic Materials sector data. For readers following this sector, 10 of 38 priced US stocks rose while 28 fell. AngloGold Ashanti Limited (AU) dropped 5.91% to USD 98.42 with a typical hold time of 47 days and a Pluang order activity of 77% Sell / 23% Buy. Gold Fields Limited (GFI) declined 5.87% to USD 40.44 with a typical hold time of 48 days and 35% Sell / 65% Buy order activity. Wheaton Precious Metals Corp (WPM) fell 5.14% to USD 145.91 with a typical hold time of 64 days and 33% Sell / 67% Buy order activity. These figures are as of Sep 23, 2026 21:22 WIB.

More News

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex's price target jumps to $88 after positive Phase III trial for chronic urticaria drug.

Celldex Therapeutics saw its price target raised from $70 to $88 by Leerink Partners following successful Phase III trial results for its drug barzolvolimab treating chronic spontaneous urticaria (CSU). The trials met all primary endpoints, showing l...

Analyst Insights
Bullish
1 hour ago
Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper stock holds steady with a raised price target amid plans to boost production by 2028.

Ero Copper, a major copper producer, shows stock volatility between $16.88 and $40.83 over the past year. Analyst firm CIBC maintained a "Neutral" rating but increased the price target to C$56.00, reflecting optimism about the company's long-term gro...

Analyst Insights
Bullish
1 hour ago
Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas reports strong Q1 with EPS $1.39 and revenue up 10.9%, beating estimates.

Cintas Corporation posted robust first-quarter results, surpassing analyst expectations with earnings per share of $1.39 and revenue of $3.01 billion, a 10.9% increase year-over-year. The company's organic revenue growth was 8.9%, reflecting solid bu...

Company Fundamentals
Bullish
2 hours ago
Oppenheimer cuts Nike price target to $52 amid sales drop and economic challenges, but sees 45% upside potential.

Oppenheimer cuts Nike price target to $52 amid sales drop and economic challenges, but sees 45% upside potential.

Oppenheimer lowered Nike's price target to $52 from a higher level, reflecting concerns over falling sales and macroeconomic challenges. Despite Nike's stock trading near its 52-week low around $35.35, the new target implies a potential 44.85% upside...

Analyst Insights
Bearish
2 hours ago
Stifel upgrades Microsoft to Buy, citing strong Azure and Copilot growth potential.

Stifel upgrades Microsoft to Buy, citing strong Azure and Copilot growth potential.

Stifel Financial upgraded Microsoft from Hold to Buy, raising its price target to $575 due to strong growth prospects in Azure cloud services and Microsoft 365 Copilot. The analyst highlighted Azure's 43% year-over-year revenue growth and over 30 mil...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App